-Automatic translation

The vaccine that will be used in vaccinations in the winter of 2023–2024 according to the Chief Epidemiologist's contracts with Vistor is Vaxigrip Tetra - 95,000 doses.

As in previous years, distribution will be prioritised to health institutions and nursing homes in the first month. It is expected that vaccinations of priority groups can begin after mid-October, but others will receive vaccinations after mid-November.

The distribution of vaccines is based on the quantity ordered or registered for use during last winter unless otherwise stated in the communication between the Chief Epidemiologist and the vaccination controller.

The Chief Epidemiologist recommends that the following risk groups be given priority in influenza vaccination:

• All persons 60 years of age or older.

• All children born 1.1.2020–30.6.2023, who have reached the age of 6 months at the time of vaccination.

• All children and adults with chronic cardiac, pulmonary, renal and hepatic diseases, obesity, diabetes, malignant diseases and other immunosuppressive diseases.

• Pregnant women.

• Healthcare professionals who care for individuals in the risk groups listed above.

The vaccine is free of charge to priority groups.

Further information:

• Circular no.  1/2023 on vaccination against annual influenza (Icelandic)

• Information from The Icelandic Medicines Agency about yearly influenza vaccination (Icelandic)

The Chief Epidemiologist